NCT02558335View on ClinicalTrials.gov

CTCs for High Grade Glioma

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

April 30, 2017

Study Completion Date

April 30, 2020

Conditions
Stage III and IV Glioma Patients
Trial Locations (1)

19104

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

Abramson Cancer Center at Penn Medicine

OTHER

NCT02558335 - CTCs for High Grade Glioma | Biotech Hunter | Biotech Hunter